Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.2971
+0.0060 (2.06%)
At close: Feb 18, 2026, 4:00 PM EST
0.3000
+0.0029 (0.98%)
Pre-market: Feb 19, 2026, 7:34 AM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $27.11 million as of February 19, 2026. Its market cap has decreased by -69.65% in one year.
Market Cap
27.11M
Enterprise Value
12.86M
1-Year Change
-69.65%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $27.11M, a decrease of -85.99%. That is a compound annual growth rate of -21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 23.40M | -2.50% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 29.18M |
| Passage Bio | 28.80M |
| BriaCell Therapeutics | 28.67M |
| NeuroSense Therapeutics | 28.49M |
| AEON Biopharma | 28.34M |
| AN2 Therapeutics | 28.22M |
| Evaxion | 27.69M |
| IO Biotech | 27.34M |